Hypertension, or high blood pressure, is a major risk factor for heart disease and stroke ([@R1]). The prevalence of hypertension is higher among men than among women, increases with age, is highest among non-Hispanic blacks (blacks) ([@R2]), and has been consistently highest in the Southeastern region of the United States ([@R1]). To update prevalence estimates for self-reported hypertension and use of antihypertensive medication, CDC analyzed data from the 2017 Behavioral Risk Factor Surveillance System (BRFSS). The overall (unadjusted) prevalence of self-reported hypertension was 32.4% (95% confidence interval \[CI\] = 32.1%--32.7%). The age-standardized, median state-specific prevalence of self-reported hypertension was 29.7% (range = 24.3%--38.6%). Overall age-standardized hypertension prevalence was higher among men (32.9%) than among women (27.0%), highest among blacks (40.0%), decreased with increasing levels of education and household income, and was generally highest in the Southeastern and Appalachian states.[\*](#FN1){ref-type="fn"} Among persons reporting hypertension, the overall unadjusted prevalence of self-reported antihypertensive medication use was 76.0% (95% CI = 75.5%--76.4%). The age-standardized, median state-specific prevalence of antihypertensive medication use among persons with reported hypertension was 59.4% (range = 50.2%--71.2%). Prevalence was higher among women than men, highest among blacks compared with other racial/ethnic groups, and highest among states in the Southeast, Appalachia, and the Dakotas. These findings can help inform CDC's initiatives to enhance hypertension awareness, treatment, and control across all states.

BRFSS[^†^](#FN2){ref-type="fn"} is an annual, random-digit--dialed telephone survey (both landline and mobile phone), representative of the noninstitutionalized adult population aged ≥18 years of the 50 states, the District of Columbia (DC), and U.S. territories. In 2017, a total of 450,016 adults were interviewed. The present study includes data from the 50 states and DC; the median response rate was 45.9% (range = 30.6%--64.1%).[^§^](#FN3){ref-type="fn"} Respondents were classified as having hypertension if they answered "yes" to the question "Have you ever been told by a doctor, nurse, or other health professional that you have high blood pressure?" Those with borderline and pregnancy-related hypertension were categorized as "no." Respondents reporting hypertension were classified as currently taking antihypertensive medication if they answered "yes" to the question "Are you currently taking medicine for your high blood pressure?" All analyses incorporated methods to account for the complex survey design. Application of sampling weights accounted for nonresponse, noncoverage, and mobile telephone--only households, and were derived from an iterative proportional weighting (raking) procedure.[^¶^](#FN4){ref-type="fn"}

The unadjusted, age-specific, and age-standardized prevalence of self-reported hypertension and antihypertensive medication use were estimated overall, for each of the 50 states and DC, and by sociodemographic characteristics. Prevalence estimates were age-standardized to the 2000 U.S. standard population ([@R3]). Differences in prevalence across sociodemographic subgroups were tested using chi-squared tests, and differences reported were considered statistically significant for p-values \<0.05. All analyses were conducted using SAS-callable SUDAAN (version 11.0.3; RTI International).

During 2017, the overall unadjusted prevalence of hypertension for the 50 states and DC was 32.4% (95% CI = 32.1%--32.7%), representing an estimated 81.7 million adults ([Table 1](#T1){ref-type="table"}). The age-standardized median state-specific prevalence of hypertension was 29.7% (range = 24.3% \[Minnesota\] to 38.6% \[Alabama and West Virginia\]). Age-standardized hypertension prevalences were generally highest in Southeastern and Appalachian states ([Figure](#F1){ref-type="fig"}). Age-specific hypertension prevalence increased with increasing age group ([Table 2](#T2){ref-type="table"}). The age-standardized prevalence of hypertension was higher among men (32.9%) than among women (27.0%), highest among blacks (40.0%), and decreased with increasing levels of education and household income.

###### Unadjusted and age-standardized[\*](#FN1){ref-type="fn"} prevalence of self-reported hypertension (HTN)[^†^](#FN2){ref-type="fn"} and current antihypertensive medication use[^§^](#FN3){ref-type="fn"} among adults aged ≥18 years --- Behavioral Risk Factor Surveillance System, 50 U.S. states and the District of Columbia, 2017

  Area                   Hypertension   Current antihypertensive medication use among adults with hypertension                                                                                                      
  ---------------------- -------------- ------------------------------------------------------------------------ ----------------------- ----------------------- ------------- ------------ ----------------------- -----------------------
  **Overall**            **178,312**    **81,674**                                                               **32.4 (32.1--32.7)**   **29.9 (29.6--30.2)**   **146,754**   **61,927**   **76.0 (75.5--76.4)**   **59.6 (58.8--60.3)**
  **State**                                                                                                                                                                                                         
  Alabama                3,435          1,582                                                                    41.9 (40.3--43.4)       38.6 (37.1--40.1)       2,954         1,281        81.1 (79.1--83.1)       70.5 (67.1--73.9)
  Alaska                 1,245          176                                                                      31.8 (29.2--34.5)       31.8 (29.4--34.2)       875           113          64.4 (59.8--69.0)       53.0 (46.7--59.2)
  Arizona                6,005          1,655                                                                    30.7 (29.8--31.5)       28.0 (27.1--28.8)       4,891         1,236        74.8 (73.2--76.3)       56.0 (53.6--58.4)
  Arkansas               2,892          949                                                                      41.4 (39.0--43.7)       38.5 (36.1--40.8)       2,547         754          79.6 (76.5--82.8)       69.3 (64.2--74.4)
  California             2,854          8,647                                                                    28.4 (27.1--29.6)       27.0 (25.9--28.1)       2,060         6,141        71.1 (68.8--73.4)       53.0 (50.0--56.0)
  Colorado               3,189          1,130                                                                    26.0 (24.9--26.9)       24.8 (23.8--25.7)       2,395         764          69.9 (67.8--72.0)       52.7 (49.6--55.8)
  Connecticut            3,991          859                                                                      30.5 (29.3--31.6)       27.2 (26.1--28.3)       3,313         658          76.8 (74.8--78.9)       57.3 (54.0--60.6)
  Delaware               1,683          263                                                                      34.9 (32.9--36.9)       31.1 (29.2--33.0)       1,367         203          77.3 (74.2--80.4)       58.8 (53.5--64.1)
  District of Columbia   1,505          149                                                                      26.4 (24.8--28.1)       28.2 (26.7--29.6)       1,241         111          74.5 (71.3--77.8)       61.7 (57.3--66.0)
  Florida                9,360          5,810                                                                    34.6 (33.2--36.0)       29.7 (28.5--31.0)       7,568         4,496        77.5 (75.5--79.5)       58.3 (54.8--61.7)
  Georgia                2,520          2,624                                                                    33.1 (31.6--34.6)       31.6 (30.2--33.0)       2,153         2,042        77.9 (75.4--80.3)       62.7 (59.0--66.4)
  Hawaii                 2,657          343                                                                      30.6 (29.2--32.0)       28.1 (26.9--29.4)       2,067         257          75.0 (72.5--77.4)       57.9 (54.3--61.5)
  Idaho                  1,806          379                                                                      29.8 (28.1--31.5)       27.5 (26.0--29.0)       1,378         260          69.0 (65.8--72.0)       50.2 (46.2--54.2)
  Illinois               2,190          3,187                                                                    32.2 (30.8--33.7)       29.9 (28.5--31.3)       1,788         2,410        75.7 (73.3--78.2)       59.8 (55.4--64.1)
  Indiana                6,226          1,796                                                                    35.2 (34.2--36.3)       32.6 (31.7--33.6)       5,262         1,372        76.5 (74.8--78.2)       60.4 (57.8--63.0)
  Iowa                   2,906          762                                                                      31.5 (30.3--32.6)       28.3 (27.3--29.4)       2,384         589          77.5 (75.5--79.4)       60.7 (57.4--64.0)
  Kansas                 8,757          718                                                                      32.8 (32.0--33.5)       30.5 (29.8--31.2)       7,187         544          75.8 (74.6--77.1)       59.2 (57.3--61.2)
  Kentucky               4,214          1,356                                                                    39.4 (37.7--41.0)       36.1 (34.6--37.6)       3,600         1,094        80.8 (78.7--82.9)       67.5 (64.1--70.9)
  Louisiana              2,208          1,400                                                                    39.0 (37.3--40.7)       36.8 (35.2--38.4)       1,849         1,123        80.3 (78.0--82.5)       69.0 (65.3--72.6)
  Maine                  3,909          376                                                                      34.8 (33.4--36.2)       29.9 (28.5--31.3)       3,117         279          74.5 (72(2--76.9)       56.5 (52.7--60.8)
  Maryland               5,982          1,522                                                                    32.4 (31.2--33.5)       29.8 (28.7--30.9)       5,179         1,211        79.7 (77.8--81.5)       62.6 (59.1--66.1)
  Massachusetts          2,475          1,564                                                                    28.6 (26.8--30.3)       25.7 (24.3--27.2)       2,053         1,220        78.1 (75.2--81.0)       59.7 (54.4--65.0)
  Michigan               4,397          2,697                                                                    34.7 (33.6--35.8)       31.3 (30.3--32.3)       3,625         2,067        76.7 (75.0--78.4)       59.4 (56.5--62.2)
  Minnesota              5,533          1,134                                                                    26.6 (25.8--27.4)       24.3 (23.5--25.0)       4,492         861          76.0 (74.3--77.6)       58.0 (55.3--60.5)
  Mississippi            2,621          926                                                                      40.8 (38.8--42.7)       38.2 (36.4--40.0)       2,314         750          81.0 (78.3--83.8)       71.2 (66.8--75.5)
  Missouri               3,133          1,513                                                                    32.0 (30.6--33.4)       29.0 (27.7--30.3)       2,671         1,204        79.7 (77.4--82.0)       64.0 (59.8--68.0)
  Montana                2,211          238                                                                      29.0 (27.5--30.5)       25.7 (24.2--27.1)       1,750         170          71.8 (68.8--74.7)       51.7 (47.5--56.0)
  Nebraska               5,895          443                                                                      30.6 (29.5--31.7)       28.2 (27.3--29.2)       4,957         348          78.6 (76.8--80.4)       61.5 (58.3--64.7)
  Nevada                 1,471          757                                                                      32.6 (30.5--34.8)       30.0 (28.1--32.0)       1,149         548          72.5 (68.9--76.2)       55.1 (49.2--61.1)
  New Hampshire          2,284          324                                                                      30.0 (28.4--31.6)       25.9 (24.4--27.4)       1,915         257          79.7 (77.0--82.3)       62.2 (56.0--68.3)
  New Jersey             4,897          2,305                                                                    33.0 (31.6--34.4)       30.1 (28.8--31.4)       4,096         1,750        76.0 (73.7--78.4)       58.3 (54.7--62.0)
  New Mexico             2,496          484                                                                      30.5 (29.0--32.0)       28.0 (26.6--29.4)       1,952         353          73.2 (70.5--75.8)       57.1 (52.9--61.3)
  New York               4,329          4,574                                                                    29.4 (28.3--30.5)       27.1 (26.2--28.1)       3,485         3,449        75.6 (73.7--77.5)       57.4 (54.6--60.2)
  North Carolina         2,002          2,775                                                                    34.7 (33.0--36.5)       31.8 (30.2--33.3)       1,662         2,217        80.0 (77.6--82.5)       64.1 (59.9--68.4)
  North Dakota           2,813          173                                                                      29.5 (28.2--30.8)       28.2 (27.0--29.4)       2,401         135          78.2 (75.9--80.6)       63.2 (59.2--67.3)
  Ohio                   5,394          3,130                                                                    34.7 (33.5--35.9)       31.4 (30.2--32.6)       4,618         2,433        77.9 (75.9--79.9)       61.5 (58.3--64.6)
  Oklahoma               3,176          1,124                                                                    37.7 (36.2--39.2)       35.4 (34.0--36.7)       2,719         874          77.8 (75.6--80.0)       64.0 (60.6--67.5)
  Oregon                 1,835          987                                                                      30.1 (28.7--31.5)       27.2 (25.9--28.5)       1,374         699          71.0 (68.4--73.5)       53.3 (49.5--57.0)
  Pennsylvania           2,337          3,295                                                                    32.6 (31.1--34.1)       28.9 (27.6--30.2)       1,896         2,586        78.6 (76.4--80.9)       60.9 (56.9--64.8)
  Rhode Island           2,303          280                                                                      33.1 (31.4--34.8)       29.9 (28.3--31.5)       1,969         226          81.0 (78.4--83.7)       65.5 (60.3--70.6)
  South Carolina         5,632          1,498                                                                    38.1 (36.9--39.3)       34.4 (33.3--35.6)       4,916         1,206        80.6 (78.9--82.4)       68.5 (65.2--71.8)
  South Dakota           2,862          203                                                                      30.8 (28.9--32.7)       28.0 (26.2--29.7)       2,420         161          79.4 (76.3--82.5)       64.8 (59.0--70.5)
  Tennessee              2,638          2,012                                                                    38.7 (36.9--40.4)       35.5 (33.9--37.2)       2,210         1,580        78.6 (76.0--81.1)       65.0 (60.9--69.1)
  Texas                  5,299          6,853                                                                    32.5 (30.8--34.2)       31.9 (30.3--33.5)       4,446         4,958        72.4 (69.4--75.3)       57.5 (53.5--61.6)
  Utah                   3,044          534                                                                      24.5 (23.4--25.5)       25.4 (24.5--26.4)       2,224         359          67.4 (65.1--69.7)       52.3 (49.6--55.1)
  Vermont                2,313          153                                                                      30.4 (28.9--31.9)       26.4 (25.1--27.8)       1,804         112          73.5 (71.0--76.1)       51.7 (47.8--55.6)
  Virginia               3,895          2,136                                                                    32.4 (31.1--33.6)       30.3 (29.1--31.5)       3,245         1,613        75.7 (73.5--77.9)       58.3 (55.1--61.5)
  Washington             4,840          1,700                                                                    29.5 (28.6--30.5)       27.6 (26.6--28.5)       3,696         1,184        69.9 (68.0--71.7)       54.5 (51.9--57.2)
  West Virginia          2,769          631                                                                      43.5 (28.6--30.5)       38.6 (37.0--40.2)       2,380         502          79.6 (77.5--81.7)       61.7 (58.4--65.1)
  Wisconsin              2,143          1,387                                                                    30.8 (29.2--32.4)       27.9 (26.4--29.4)       1,743         1,041        75.4 (72.6--78.2)       57.0 (52.4--61.5)
  Wyoming                1,741          138                                                                      30.8 (29.2--32.4)       28.5 (27.0--30.0)       1,397         98           71.7 (68.8--74.7)       53.5 (49.4--57.6)
  Median                 ---            ---                                                                      32.2                    29.7                    ---           ---          76.7                    59.4
  Range                  ---            ---                                                                      24.5--43.5              24.3--38.6              ---           ---          64.4--81.1              50.2--71.2

**Abbreviation**: CI = confidence interval.

\* Age standardized to the 2000 U.S. projected population using three age groups: 18--44, 45--64, and ≥65 years.

^†^ Hypertension was defined as an affirmative response to "Have you ever been told by a doctor, nurse, or other health professional that you have high blood pressure?" Preeclampsia or borderline high or prehypertensive was categorized as "no."

^§^ Current antihypertensive medication use was defined as affirmative response to "Are you currently taking medicine prescribed by a doctor or other health professional for your high blood pressure?"

^¶^ Weighted number of adults in the population with hypertension or currently using antihypertensive medication.

![Age-standardized percentage of self-reported hypertension and antihypertensive medication use among adults aged ≥18 years, by state --- Behavioral Risk Factor Surveillance System, United States, 2017\
**Abbreviation:** DC = District of Columbia.](mm6914a1-F){#F1}

###### Unadjusted and age-standardized[\*](#FN1){ref-type="fn"} prevalence of self-reported hypertension (HTN)[^†^](#FN2){ref-type="fn"} and antihypertensive medication use[^§^](#FN3){ref-type="fn"} among adults aged ≥18 years, by selected characteristics --- Behavioral Risk Factor Surveillance System, United States, 2017

  Characteristic                                   Hypertension   Antihypertensive medication use among adults with hypertension                                                                                                      
  ------------------------------------------------ -------------- ---------------------------------------------------------------- ----------------------- ----------------------- ------------- ------------ ----------------------- -----------------------
  **Overall**                                      **178,312**    **81,674**                                                       **32.4 (32.1--32.7)**   **29.9 (29.6--30.2)**   **146,754**   **61,927**   **76.0 (75.5--76.4)**   **59.6 (58.8--60.3)**
  **Age group (yrs)**                                                                                                                                                                                                                 
  18--44                                           18,432         16,429                                                           14.1 (13.7--14.5)       14.1 (13.8--14.5)       7,512         6,195        37.9 (36.5--39.2)       37.9 (36.5--39.2)
  45--64                                           66,699         34,048                                                           40.5 (40.0--41.0)       40.5 (40.0--41.0)       53,783        27,085       79.6 (78.9--80.3)       79.6 (78.9--80.3)
  ≥65                                              93,181         31,198                                                           60.5 (60.0--61.1)       60.5 (60.0--61.1)       85,459        28,647       92.0 (91.5--92.4)       92.0 (91.5--92.4)
  **Sex\***                                                                                                                                                                                                                           
  Men                                              81,648         42,260                                                           34.5 (34.0--34.9)       32.9 (32.5--33.3)       64,010        30,136       71.5 (70.7--72.2)       56.7 (55.8--57.6)
  Women                                            96,569         39,363                                                           30.4 (30.0--30.8)       27.0 (26.6--27.3)       82,669        31,747       80.8 (80.1--81.4)       64.0 (62.7--65.2)
  **Race/Ethnicity\***                                                                                                                                                                                                                
  White, non-Hispanic                              136,668        53,179                                                           34.0 (33.7--34.3)       29.0 (28.7--29.3)       113,525       41,278       77.7 (77.2--78.2)       59.0 (58.1--59.9)
  Black, non-Hispanic                              18,628         12,127                                                           41.1 (40.1--42.1)       40.0 (39.2--40.9)       16,116        9,649        79.6 (78.3--80.9)       68.1 (66.2--70.0)
  Hispanic                                         9,081          9,510                                                            23.9 (23.0--24.7)       28.2 (27.3--29.1)       6,359         6,133        64.8 (62.8--66.8)       54.0 (51.9--56.0)
  American Indian/Alaska Native, non-Hispanic      3,624          976                                                              38.8 (36.4--41.3)       37.1 (34.7--39.5)       2,784         690          70.7 (66.7--74.7)       58.6 (53.6--63.5)
  Asian, non-Hispanic                              2,290          2,659                                                            19.6 (17.8--21.4)       23.8 (21.9--25.8)       1,786         1,835        69.2 (64.5--73.9)       58.0 (52.8--63.0)
  Native Hawaiian/Pacific Islander, non-Hispanic   316            127                                                              26.4 (21.2--31.7)       33.0 (28.3--38.0)       200           87           68.4 (59.1--77.6)       54.9 (45.8--63.6)
  Multiracial, non-Hispanic                        3,373          1,060                                                            30.1 (28.3--32.0)       31.6 (29.9--33.4)       2,504         731          69.1 (65.9--72.3)       56.7 (52.8--60.6)
  Other, non-Hispanic                              880            368                                                              33.1 (28.8--37.3)       28.9 (25.3--32.8)       703           276          75.2 (67.9--82.5)       54.9 (45.4--64.0)
  **Education level\***                                                                                                                                                                                                               
  Less than high school                            15,316         13,232                                                           39.1 (38.1--40.2)       35.4 (34.4--36.3)       12,605        10,020       75.9 (74.4--77.4)       58.6 (56.4--60.8)
  High school or equivalent                        54,498         24,742                                                           35.2 (34.6--35.7)       32.3 (31.8--32.8)       45,423        18,944       76.7 (75.9--77.6)       59.6 (58.4--60.9)
  More than high school                            107,886        43,411                                                           29.5 (29.2--29.9)       27.5 (27.2--27.8)       88,234        32,756       75.6 (74.9--76.2)       59.8 (58.8--60.8)
  **Household income\***                                                                                                                                                                                                              
  \<\$15,000                                       17,836         9,145                                                            40.7 (39.6--41.8)       37.9 (36.9--39.0)       14,384        6,889        75.5 (73.9--77.1)       61.5 (59.3--63.7)
  \$15,000 to \<\$25,000                           28,614         13,017                                                           36.9 (36.1--37.7)       34.3 (33.6--35.1)       23,605        9,895        76.1 (74.9--77.4)       59.7 (57.9--61.5)
  \$25,000 to \<\$35,000                           17,502         7,731                                                            35.5 (34.5--36.6)       31.9 (30.9--32.9)       14,589        5,928        76.8 (75.3--78.4)       60.4 (57.5--63.2)
  \$35,000 to \<\$50,000                           22,129         9,213                                                            33.1 (32.3--34.0)       29.9 (29.1--30.7)       18,451        7,029        76.4 (75.0--77.8)       56.9 (54.9--58.8)
  ≥\$50,000                                        61,667         29,012                                                           28.2 (27.8--28.7)       26.9 (26.5--27.3)       49,890        21,529       74.3 (73.5--75.1)       59.7 (58.5--60.9)

**Abbreviation**: CI = confidence interval.

\*Age standardized to the 2000 U.S. projected population using three age groups: 18--44, 45--64, and ≥65 years.

^†^ Hypertension was defined as an affirmative response to "Have you ever been told by a doctor, nurse, or other health professional that you have high blood pressure?" Preeclampsia or borderline high or pre-hypertensive was categorized as "no."

^§^ Current antihypertensive medication use was defined as affirmative response to "Are you currently taking medicine prescribed by a doctor or other health professional for your high blood pressure?"

^¶^ Weighted number of adults in the population with hypertension or currently using antihypertensive medication.

Among those reporting hypertension, the overall, unadjusted prevalence of antihypertensive medication use was 76.0% (95% CI = 75.5%--76.4%), representing an estimated 61.9 million adults ([Table 1](#T1){ref-type="table"}). The age-standardized, median, state-specific prevalence of antihypertensive medication use was 59.4% (range = 50.2% \[Idaho\] to 71.2% \[Mississippi\]). Age-standardized prevalence of antihypertensive medication use was highest in the Southeastern and Appalachian states, as well as the Dakotas ([Figure](#F1){ref-type="fig"}). The age-specific prevalence of antihypertensive medication use also increased with increasing age ([Table 2](#T2){ref-type="table"}), was highest among blacks (68.1%), was higher among women (64.0%) than among men (56.7%), and did not vary by education or household income level.

Discussion
==========

During 2017, approximately one third (82 million) of U.S. adults reported having hypertension, and an estimated three quarters of those with hypertension (62 million) reported using antihypertensive medication. Age-standardized prevalence of hypertension varied widely by state, remaining highest in the Southeast and among men and blacks. Age-standardized prevalence of antihypertensive medication use also increased with increasing age, was highest among blacks, and was higher among women than among men.

The overall age-standardized self-reported hypertension prevalence of 29.9% was similar to that reported based on 2011--2015 BRFSS data (29.8%) ([@R1]) and measured hypertension prevalence of 29% based on data from the 2015--2016 National Health and Nutrition Examination Survey ([@R2]). Also consistent with other reports, hypertension prevalence decreased with increasing income ([@R4]) and education level ([@R1]) and was highest in Southeastern and Appalachian states ([@R1],[@R2]). The overall, age-standardized prevalence of antihypertensive medication use (59.6%) was also similar to estimates from the 2011--2015 BRFSS, ranging from 63.0% in 2011 to 61.8% in 2015 ([@R1]). Like hypertension prevalence, medication use prevalence was highest in Southeastern and Appalachian states. In the present study, prevalence of medication use was also highest in the Dakotas, despite a midrange prevalence of hypertension in these states. Prevalence of antihypertensive medication use was higher in older age groups, highest among blacks, and higher among women than men. This overall gender difference has been reported previously ([@R1]), but the reasons are unclear. Data from Medicare Part D beneficiaries aged ≥65 years suggest that antihypertensive medication nonadherence is similar for men (25.8%) and women (26.7%) ([@R5]). More information is needed to examine the relationship between the prevalence of self-reported hypertension and that of antihypertensive medication use.

The findings in this report are subject to at least three limitations. First, data were self-reported. The lack of documented diagnosis of hypertension based on historic blood pressure measurements does not allow for precise assessment of hypertension; however, the results were similar to data from previous reports based on both self-report ([@R1]) and measured hypertension ([@R2]). Second, low median response rates across states might limit the representativeness of the 2017 BRFSS sample and potentially result in either under- or overestimates of prevalence, although application of sampling weights is likely to reduce some nonresponse bias. Finally, findings are representative of noninstitutionalized civilian persons only and would exclude those living in nursing homes, prisons, and other institutions.

This report provides the most recent state-level surveillance data on prevalence of self-reported hypertension and antihypertensive medication use among persons reporting hypertension. Hypertension prevention and control is a priority of CDC's state and local funding for heart disease and stroke prevention[\*\*](#FN5){ref-type="fn"} and one of the important elements of the Million Hearts initiative ([@R6]). CDC has been working closely with states to enhance hypertension management through a strategy of team-based care in which two or more health care providers work collaboratively with each patient. These teams may include doctors, nurses, pharmacists, dietitians, community health workers, and other health care providers. This approach is often multidisciplinary with a team working to educate patients, identify risk factors, provide treatments, and sustain ongoing conversations with patients. This strategy can result in multiple opportunities for intervention for better blood pressure control ([@R7]),[^††^](#FN6){ref-type="fn"} with the ultimate goal of reducing disparities in hypertension awareness, treatment, and control across the United States.

###### Summary

What is already known about this topic?
---------------------------------------

Prevalence of hypertension increases with increasing age and is higher among men than women and among non-Hispanic blacks than among other racial/ethnic groups; prevalence has been consistently higher in the Southeastern and Appalachian regions of the United States.

What is added by this report?
-----------------------------

Analysis of 2017 Behavioral Risk Factor Surveillance System data found that approximately one third of U.S. adults reported having hypertension, and an estimated 75% of those reporting having hypertension reported using antihypertensive medication. The prevalence of these factors varied widely by state and was generally highest in the Southeastern and Appalachian states.

What are the implications for public health practice?
-----------------------------------------------------

A multidisciplinary team-based strategy working to educate patients, maintain dialogue over time, and identify risk factors can provide intervention opportunities for better blood pressure control and could reduce disparities in hypertension awareness, treatment, and control across the United States.

<https://www.arc.gov/appalachian_region/TheAppalachianRegion.asp>.

<https://www.cdc.gov/brfss/index.html>.

<https://www.cdc.gov/brfss/annual_data/2017/pdf/2017-sdqr-508.pdf>.

<https://www.cdc.gov/brfss/annual_data/2017/pdf/weighting-2017-508.pdf>.

<https://www.cdc.gov/dhdsp/programs/index.htm>.

<https://www.cdc.gov/dhdsp/pubs/guides/best-practices/team-based-care.htm>.
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